“I would encourage others to join D2d for opportunities to learn about type 2 diabetes.”
Paul Thibodeau learned about D2d through a clinical trials newsletter and was immediately interested in joining the study to learn more about type 2 diabetes. He was diagnosed with type 2 diabetes in the past and he believed that D2d is a great opportunity to monitor his diabetes risk during follow-up study visits that occur twice a year.
Paul enjoys being part of the D2d team so much that he says “I would encourage others to join D2d for opportunities to learn about type 2 diabetes.” He even shared his D2d experience with his friends and relatives. Paul’s endocrinologist is also very interested in the D2d study. He has been following D2d study updates and is looking forward to the outcomes and results of the study.